Potential Target, page-10

It should hit serious resistance at 49-50c having been there before and been unable to break higher.

However, if the stock is trading at 47-48c and there is meaningful news on oncology asset sales, milestone payment from Merck for BNC 375 or a buildup in expectations about BNC 210, then it could blow straight through 50c and keep tracking higher with virtually no technical overhead resistance............

There are lot of ifs and buts in there but from a technical (ie charting) perspective, its looking very promising (again).

GLTA